European Stroke Organisation (ESO)–European Society for Minimally Invasive Neurological Therapy (ESMINT) expedited recommendation on indication for intravenous thrombolysis before mechanical thrombectomy in patients with acute ischemic stroke and anterior circulation large vessel occlusion

Six randomized controlled clinical trials have assessed whether mechanical thrombectomy (MT) alone is non-inferior to intravenous thrombolysis (IVT) plus MT within 4.5 hours of symptom onset in patients with anterior circulation large vessel occlusion (LVO) ischemic stroke and no contraindication to IVT. An expedited recommendation process was initiated by the European Stroke Organisation (ESO) and conducted with the European Society of Minimally Invasive Neurological Therapy (ESMINT) according to ESO standard operating procedure based on the GRADE system. We identified two relevant Population, Intervention, Comparator, Outcome (PICO) questions, performed systematic reviews and meta-analyses of the literature, assessed the quality of the available evidence, and wrote evidence-based recommendations. Expert opinion was provided if insufficient evidence was available to provide recommendations based on the GRADE approach. For stroke patients with anterior circulation LVO directly admitted to a MT-capable center (‘mothership’) within 4.5 hours of symptom onset and eligible for both treatments, we recommend IVT plus MT over MT alone (moderate evidence, strong recommendation). MT should not prevent the initiation of IVT, nor should IVT delay MT. In stroke patients with anterior circulation LVO admitted to a center without MT facilities and eligible for IVT ≤4.5 hours and MT, we recommend IVT followed by rapid transfer to a MT capable-center (‘drip-and-ship’) in preference to omitting IVT (low evidence, strong recommendation). Expert consensus statements on ischemic stroke on awakening from sleep are also provided. Patients with anterior circulation LVO stroke should receive IVT in addition to MT if they have no contraindications to either treatment.

[1]  J. Wassélius,et al.  Endovascular thrombectomy for acute ischemic stroke , 2022, Journal of Internal Medicine.

[2]  Xiang Li,et al.  Mechanical Thrombectomy with or without Intravenous Thrombolysis in Acute Ischemic Stroke: A Meta-Analysis for Randomized Controlled Trials , 2021, European Neurology.

[3]  D. Werring,et al.  Intravenous Thrombolysis Before Mechanical Thrombectomy for Acute Ischemic Stroke: A Meta‐Analysis , 2021, Journal of the American Heart Association.

[4]  Y. Cho,et al.  Direct Endovascular Thrombectomy Alone vs. Bridging Thrombolysis for Patients with Acute Ischemic Stroke , 2021, Clinical Neuroradiology.

[5]  L. Beenen,et al.  A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. , 2021, The New England journal of medicine.

[6]  M. Wiesmann,et al.  SWIFT DIRECT: Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke: Methodology of a randomized, controlled, multicentre study , 2021, International journal of stroke : official journal of the International Stroke Society.

[7]  B. Norrving,et al.  European Stroke Organisation (ESO) standard operating procedure for the preparation and publishing of guidelines , 2021, European stroke journal.

[8]  O. Naggara,et al.  Influence of prior intravenous thrombolysis on outcome after failed mechanical thrombectomy: ETIS registry analysis , 2021, Journal of NeuroInterventional Surgery.

[9]  Zhijian Liang,et al.  Direct endovascular treatment versus bridging therapy in patients with acute ischemic stroke eligible for intravenous thrombolysis: systematic review and meta-analysis , 2021, Journal of NeuroInterventional Surgery.

[10]  C. Molina,et al.  Direct to Angiography Suite Without Stopping for Computed Tomography Imaging for Patients With Acute Stroke: A Randomized Clinical Trial. , 2021, JAMA neurology.

[11]  J. Grotta,et al.  Standardized Nomenclature for Modified Rankin Scale Global Disability Outcomes , 2021, Stroke.

[12]  S. Nagel,et al.  Efficacy and safety of bridging thrombolysis initiated before transfer in a drip-and-ship stroke service , 2021, Stroke and vascular neurology.

[13]  J. Saver,et al.  Endovascular thrombectomy without versus with intravenous thrombolysis in acute ischemic stroke: a non-inferiority meta-analysis of randomized clinical trials , 2021, Journal of NeuroInterventional Surgery.

[14]  M. Goyal,et al.  Is concurrent intravenous alteplase in patients undergoing endovascular treatment for large vessel occlusion stroke cost-effective even if the cost of alteplase is only US$1? , 2021, Journal of NeuroInterventional Surgery.

[15]  A. Alexandrov,et al.  Utility of Intravenous Alteplase Prior to Endovascular Stroke Treatment , 2021, Neurology.

[16]  C. Nolte,et al.  Endovascular Therapy for Stroke Due to Basilar-Artery Occlusion. , 2021, The New England journal of medicine.

[17]  J. Grotta,et al.  Clinical and Neuroimaging Outcomes of Direct Thrombectomy vs Bridging Therapy in Large Vessel Occlusion , 2021, Neurology.

[18]  Ana Catarina Fonseca,et al.  European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke , 2021, European stroke journal.

[19]  Hester F. Lingsma,et al.  MR CLEAN-NO IV: intravenous treatment followed by endovascular treatment versus direct endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion—study protocol for a randomized clinical trial , 2021, Trials.

[20]  R. Nogueira,et al.  Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. , 2021, JAMA.

[21]  T. Ueda,et al.  Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. , 2021, JAMA.

[22]  D. Werring,et al.  Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial , 2021, International journal of stroke : official journal of the International Stroke Society.

[23]  A. Malhotra,et al.  Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion , 2020, Stroke.

[24]  C. Gerloff,et al.  Intravenous alteplase for stroke with unknown time of onset guided by advanced imaging: systematic review and meta-analysis of individual patient data , 2020, The Lancet.

[25]  R. Nogueira,et al.  Large Vessel Occlusion Strokes After the DIRECT-MT and SKIP Trials , 2020, Stroke.

[26]  G. Tsivgoulis,et al.  Mothership versus Drip-and-Ship Model for Mechanical Thrombectomy in Acute Stroke: A Systematic Review and Meta-Analysis for Clinical and Radiological Outcomes , 2020, Journal of stroke.

[27]  J. D. Gould Letter by Gould Regarding Article, "Endovascular Thrombectomy for Acute Ischemic Strokes: Current US Access Paradigms and Optimization Methodology". , 2020, Stroke.

[28]  Y. Zhou,et al.  Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. , 2020, The New England journal of medicine.

[29]  T. Iwama,et al.  Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset , 2020, Stroke.

[30]  A. Alexandrov,et al.  Timing of Recanalization and Functional Recovery in Acute Ischemic Stroke , 2020, Journal of stroke.

[31]  F. Zhou,et al.  Endovascular treatment versus standard medical treatment for vertebrobasilar artery occlusion (BEST): an open-label, randomised controlled trial , 2019, The Lancet Neurology.

[32]  Correction to: Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[33]  W. Powers,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. , 2019, Stroke.

[34]  A. Alexandrov,et al.  Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions , 2019, Annals of neurology.

[35]  Natalie S Blencowe,et al.  RoB 2: a revised tool for assessing risk of bias in randomised trials , 2019, BMJ.

[36]  Geoffrey A. Donnan,et al.  Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data , 2019, The Lancet.

[37]  Á. Chamorro,et al.  Transfer to the Local Stroke Center versus Direct Transfer to Endovascular Center of Acute Stroke Patients with Suspected Large Vessel Occlusion in the Catalan Territory (RACECAT): Study protocol of a cluster randomized within a cohort trial , 2019, International journal of stroke : official journal of the International Stroke Society.

[38]  J. Jeng,et al.  Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke , 2019, The New England journal of medicine.

[39]  C. Kessler,et al.  Extending the time window for intravenous thrombolysis in acute ischemic stroke using magnetic resonance imaging-based patient selection , 2019, International journal of stroke : official journal of the International Stroke Society.

[40]  M. Mazighi,et al.  European Stroke Organisation (ESO) – European Society for Minimally Invasive Neurological Therapy (ESMINT) Guidelines on Mechanical Thrombectomy in Acute Ischaemic StrokeEndorsed by Stroke Alliance for Europe (SAFE) , 2019, European stroke journal.

[41]  V. Feigin,et al.  Access to and delivery of acute ischaemic stroke treatments: A survey of national scientific societies and stroke experts in 44 European countries , 2018, European stroke journal.

[42]  M. Jayaraman,et al.  Door-in-Door-Out Time at Primary Stroke Centers May Predict Outcome for Emergent Large Vessel Occlusion Patients , 2018, Stroke.

[43]  J. Baron,et al.  Post-Thrombolysis Recanalization in Stroke Referrals for Thrombectomy: Incidence, Predictors, and Prediction Scores , 2018, Stroke.

[44]  M. Mazighi,et al.  Intravenous Thrombolysis Prior to Mechanical Thrombectomy in Acute Ischemic Stroke: Silver Bullet or Useless Bystander? , 2018, Journal of stroke.

[45]  Heather B. Roesly Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging , 2018, The Journal of Emergency Medicine.

[46]  C. Gerloff,et al.  MRI‐Guided Thrombolysis for Stroke with Unknown Time of Onset , 2018, The New England journal of medicine.

[47]  E. Lindsay Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct , 2018 .

[48]  W. Powers,et al.  2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2018, Stroke.

[49]  A. Alexandrov,et al.  Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions , 2018, Stroke.

[50]  A. Alexandrov,et al.  Primary Thrombectomy in tPA (Tissue-Type Plasminogen Activator) Eligible Stroke Patients With Proximal Intracranial Occlusions , 2018, Stroke.

[51]  J. Saver,et al.  Direct Mechanical Thrombectomy Versus Combined Intravenous and Mechanical Thrombectomy in Large-Artery Anterior Circulation Stroke: A Topical Review , 2017, Stroke.

[52]  G. Schroth,et al.  Impact of intravenous thrombolysis on recanalization rates in patients with stroke treated with bridging therapy , 2017, European journal of neurology.

[53]  Noreen Kamal,et al.  Drip ‘n Ship Versus Mothership for Endovascular Treatment: Modeling the Best Transportation Options for Optimal Outcomes , 2017, Stroke.

[54]  J. Saver,et al.  Minimal Clinically Important Difference for Safe and Simple Novel Acute Ischemic Stroke Therapies , 2017, Stroke.

[55]  J. Baron,et al.  Incidence and Predictors of Early Recanalization After Intravenous Thrombolysis: A Systematic Review and Meta-Analysis , 2016, Stroke.

[56]  C. Molina,et al.  Suspected Large Vessel Occlusion: Should Emergency Medical Services Transport to the Nearest Primary Stroke Center or Bypass to a Comprehensive Stroke Center With Endovascular Capabilities? , 2016, Stroke.

[57]  P. Kaňovský,et al.  Posterior vs. Anterior Circulation Infarction: Demography, Outcomes, and Frequency of Hemorrhage after Thrombolysis , 2015, International journal of stroke : official journal of the International Stroke Society.

[58]  H. Diener,et al.  The European Stroke Organisation Guidelines: a standard operating procedure , 2015, International journal of stroke : official journal of the International Stroke Society.

[59]  Andrew E. Hanselman,et al.  Topical Review , 2015, Foot & ankle specialist.

[60]  Yilong Wang,et al.  Cost-Effectiveness of Thrombolysis within 4.5 Hours of Acute Ischemic Stroke in China , 2014, PloS one.

[61]  M. Wintermark,et al.  Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2013, Stroke.

[62]  G. Guyatt,et al.  GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. , 2011, Journal of clinical epidemiology.

[63]  D. Tanné,et al.  Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study , 2009, The Lancet Neurology.

[64]  M. Kaste,et al.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. , 2008, The New England journal of medicine.

[65]  Keith Muir,et al.  Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial , 2008, The Lancet Neurology.

[66]  E. Dooley National Institute of Neurological Disorders and Stroke , 2006 .

[67]  C. Seager Therapies , 1973, Journal of the Neurological Sciences.

[68]  G. Samsa,et al.  Have Randomized Controlled Trials of Neuroprotective Drugs Been Underpowered?: An Illustration of Three Statistical Principles , 2001, Stroke.

[69]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[70]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[71]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.